Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: A missing link?

International Urology and Nephrology

Volumn 39, Issue 4, 2007, Pages 1107-1113

  van Renterghem, Koenraad ^a   Van Koeveringe, Gommert ^b   Van Kerrebroeck, Philip ^b  

^a VIRGA JESSE HOSPITAL   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Pressure flowmetry; Prostate cancer; Prostate specific antigen; Transurethral resection of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CORRELATION ANALYSIS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; FLOW MEASUREMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION; URODYNAMICS;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; URODYNAMICS;

EID: 36649016000     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-007-9209-7     Document Type: Article

References (30)

1. Kirby RS (1992) The clinical assessment of benign prostatic hyperplasia. Cancer 70:284-290
2. Stamey TA, Yang N, Hay AR et al (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909-916
3. Ercole CJ, Lange PH, Mathisen M et al (1987) Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138:1181-1184
4. Griffiths D, Hofner K, van Mastrigt R et al (1997) Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 16:1-18
5. Claridge M, Shuttleworth KE (1964) The dynamics of obstructed micturition. Invest Urol 25:188-199
6. Marberger MJ, Andersen JT, Nickel JC et al (2000) Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol 38:563-568
7. Tubaro A, La Vecchia C (2004) The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: An Italian survey. Eur Urol 45:767-772
8. Mochtar CA, Kiemeney LA, Laguna MP et al (2005) Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. Urology 65:300-305
9. Boccon-Gibod L, van der Kwast TH, Montironi R et al (2004) Handling and pathology reporting of prostate biopsies. Eur Urol 46:177-181
10. Rosai J (2004) Ackerman's surgical pathology. ed. 9, Mosby Year Book. St. Louis
11. Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826-830
12. Djavan B, Ravery V, Zlotta A et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? J Urol 166:1679-1683
13. Djavan B, Fong YK, Ravery V et al (2005) Are repeat biopsies required in men with PSA levels < or = 4 ng/ml? A Multiinstitutional Prospective European Study. Eur Urol 47:38-44
14. Chon CH, Lai FC, McNeal JE et al (2002) Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol 167:2457-2460
15. Durkan GC, Sheikh N, Johnson P et al (2002) Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 89:33-39
16. Arnold MD, Niemann TH, Bahnson RR (2001) Extended sector biopsy for detection of carcinoma of the prostate. Urol Oncol 6:91-93
17. Eskew LA, Bare RL, McCullough DL (1997) Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157:199-202
18. Laniado ME, Ockrim JL, Marronaro A et al (2004) Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 94:1283-1286
19. Gerstenberg TC, Andersen JT, Klarskov P et al (1982) High flow infravesical obstruction in men: Symptomatology, urodynamics and the results of surgery. J Urol 127:943-945
20. Carter PG, Lewis P, Abrams P (1991) Urodynamic morbidity and dysuria prophylaxis. Br J Urol 67:40-41
21. Rodrigues P, Lucon AM, Freire GC et al (2001) Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection. J Urol 165:499-502
22. McNeal JE, Redwine EA, Freiha FS et al (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897-906
23. Greene DR, Wheeler TM, Egawa S et al (1991) A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146:1069-1076
24. Shannon BA, McNeal JE, Cohen RJ (2003) Transition zone carcinoma of the prostate gland: A common indolent tumour type that occasionally manifests aggressive behaviour. Pathology 35:467-471
25. Radhakrishnan S, Dorkin TJ, Sheikh N et al (2004) Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies. Prostate Cancer Prostatic Dis 7:338-342 338-342
26. Kitamura H, Masumori N, Tanuma Y et al (2002) Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? Int J Urol 9:95-99
27. Zigeuner R, Schips L, Lipsky K et al (2003) Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 62:883-887
28. Bratt O (2006) The difficult case in prostate cancer diagnosis-when is a "diagnostic TURP" indicated? Eur Urol 49:769-771
29. Abrams P, Blaivas J, Griffiths DJ, Nordling J, Koyanagi T, Neal D, et al (1993) The objective evaluation of bladder outflow obstruction. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G, eds. Proceedings of the 2nd international consultation on benign prostatic hyperplasia. Jersey: Jersey Scientific Communication, 153-209
30. Abrams P, Blaivas J, Griffiths DJ, Nordling J, Koyanagi T, Neal D, et al (1993) The objective evaluation of bladder outflow obstruction. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G, eds. Proceedings of the 2nd international consultation on benign prostatic hyperplasia. Jersey: Jersey Scientific Communication, 153-209